Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug 1;33(4):430-435.
doi: 10.1097/MOP.0000000000001029.

Pheochromocytomas and paragangliomas

Kevin Yen  1 , Maya Lodish
Affiliations
Review

Pheochromocytomas and paragangliomas

Kevin Yen et al. Curr Opin Pediatr. .

Abstract

Purpose of review: Great progress has been made in understanding the genetic and molecular basis of pheochromocytoma and paragangliomas (PPGLs). This review highlights the new standards in the diagnosis and management of pediatric PPGLs.

Recent findings: The vast majority of pediatric PPGLs have an associated germline mutation, making genetic studies imperative in the work up of these tumors. Somatostatin receptor-based imaging modalities such as 68Ga-DOTATATE and 64Cu-DOTATATE are shown to have the greatest sensitivity in pediatric PPGLs. Peptide receptor radionuclide therapies (PRRTs) such as 177Lu-DOTATATE are shown to have efficacy for treating PPGLs.

Summary: Genetics play an important role in pediatric PPGLs. Advances in somatostatin receptor-based technology have led to use of 68Ga-DOTATATE and 64Cu-DOTATATE as preferred imaging modalities. While surgery remains the mainstay for management of PPGLs, PRRT is emerging as a treatment option for PPGLs.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interests: none

Figures

Figure 1.
Figure 1.
68Ga-DOTATATE PET/CT scan of abdominal paraganglioma due to SDHB mutation.
See this image and copyright information in PMC

References

    1. Waguespack SG, Ying AK: CHAPTER 14 - Pheochromocytoma and multiple endocrine neoplasia syndromes. In Pediatric Endocrinology (Fourth Edition). Edited by Sperling MA. W.B. Saunders; 2014:533–568.e1.
    1. Wyszyńska T, Cichocka E, Wieteska-Klimczak A, et al.: A single pediatric center experience with 1025 children with hypertension. Acta Paediatr Oslo Nor 1992 1992, 81:244–246. - PubMed
    1. Lo CY, Lam KY, Wat MS, et al.: Adrenal pheochromocytoma remains a frequently overlooked diagnosis. Am J Surg 2000, 179:212–215. - PubMed
    1. Ebbehoj A, Stochholm K, Jacobsen SF, et al.: Incidence and Clinical Presentation of Pheochromocytoma and Sympathetic Paraganglioma: A Population-based Study. J Clin Endocrinol Metab 2021, doi:10.1210/clinem/dgaa965. - DOI - PubMed
    1. Lam AK: Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours. Endocr Pathol 2017, 28:213–227. - PubMed